Bristol-Myers Squibb to Take Part in Barclays Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will present at Barclays Global Healthcare Conference on Wednesday, March 14, 2018, in Miami. Murdo Gordon, executive vice president and chief commercial officer, will answer questions about the company at 1:35 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, and YouTube.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180307006252/en/

Bristol-Myers Squibb Company
Media:
Ken Dominski, 609-252-5251
[email protected]
or
Investors:
Timothy Power, 609-252-7509
[email protected]
or
Bill Szablewski, 609-252-5894
[email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• BMS presents five-year Camzyos data for heart condition at ESC
• 3 E Network Secures $1.2 Million Enterprise DDR4 Memory Sales Order
• XCF Global (NASDAQ:SAFX) Advances Commercial Execution: Produces 886,000+ Gallons of Renewable Diesel and Monetizes Initial 550,000 D4 RINs for $1.25 Million